Отчет об анализе объема, доли и тенденций мирового рынка тестирования на С-реактивный белок – обзор отрасли и прогноз до 2032 года

Анализ рынка тестирования на С-реактивный белок

Повышенные уровни С-реактивного белка связаны с повышенным риском сердечных приступов; однако тест на С-реактивный белок не определяет прямую причину воспаления, а скорее уровень воспаления, вызванного другими факторами. Тест на С-реактивный белок используется у пациентов, у которых низкий риск сердечного приступа в ближайшие несколько лет, около 5–10%.

Объем рынка тестирования С-реактивного белка

Объем мирового рынка тестирования на С-реактивный белок в 2024 году оценивался в 5,72 млрд долларов США, а к 2032 году, по прогнозам, он достигнет 6,27 млрд долларов США, при этом среднегодовой темп роста составит 1,15% в прогнозируемый период с 2025 по 2032 год.

Область отчета и сегментация рынка       

C-Reactive Protein Testing Market Definition

The C-reactive protein (CRP) test determines the amount of C-reactive protein (CRP) in the blood. The C-reactive protein (CRP) test is used to check for infections or other medical disorders, and it rise when there is inflammation. The C-reactive protein test assesses the risk of developing cardiovascular conditions, including coronary artery disease, leading to a significant heart attack.

C-Reactive Protein Market Dynamics

Drivers

• An exponential increase in research on various applications of the C-reactive protein

The increased use of techniques such as point-of-care (POC) based testing for reliable findings and approvals of C-reactive protein testing to diagnose bacterial and non-bacterial infections is projected to boost the market growth. Furthermore, cardiovascular disorders are rising, as is the number of tests required.

• Increasing incidence of inflammatory disorders

Inflammatory disorders such as inflammatory bowel disease, endometriosis, cancer, rheumatoid arthritis, cardiovascular disease, and lupus are all diagnosed with C-reactive protein tests. When high CRP is combined with other risk factors such as hypertension, high blood pressure, diabetes, and high cholesterol, it can suggest significant heart disease. Early identification of these disorders can significantly lower the risk of heart attacks and strokes. CRP is used to discover novel medicines for inflammatory illnesses in vitro and in vivo.

• Growing cases of endometriosis in women

Endometriosis is when the uterine tissue grows outside of the uterus. The disease most commonly affects a woman's ovaries, fallopian tubes, and pelvic tissue. The condition has the potential to expand beyond the pelvic area. Endometriosis patients have a higher sensitivity to C-reactive protein than non-endometriosis patients. As a result, the test is widely used to detect the disease in patients.

Opportunities

A high C-reactive protein level in a patient with a previous heart attack history has a significant risk of having another heart attack. Hence, the C-reactive protein test can help determine the risk of a second heart attack. Furthermore, according to the study, liver cells create C-reactive protein, which is employed as a marker for determining cardiovascular disease. Patients suffering from autoimmune disorders such as rheumatoid arthritis and lupus are frequently tested for C-reactive protein, as these diseases produce inflammation.

Restraints/Challenges

The scarcity of competent and trained professionals and the availability of alternatives in the market are both factors limiting market growth.

This C-reactive protein market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the C-reactive protein market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

C-Reactive Protein Market Scope

The C-reactive protein market is segmented on the basis of assay type, detection range, disease, analysis mode, product type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Assay Type

• Immunoturbidimetric Assay
• ELISA
• Chemiluminescence Immunoassay
• Others

Detection Range

• hs-CRP
• Conventional CRP
• cCRP

Disease

• Cardiovascular Diseases

• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis

• Lupus
• Syphilis
• Inflammatory Diseases
• Diabetes
• Others

Analysis Mode

• Serum
• Plasma
• Blood

End- User

• Clinics
• Hospitals
• Laboratories
• Assisted Living Healthcare Facilities
• Home
• Others

Product Type

• Kits
• Reagents

C-Reactive Protein Market Regional Analysis

The C-reactive protein market is analyzed and market size insights and trends are provided by country, assay type, detection range, disease, analysis mode, product type and end-user, as referenced above.

The countries covered in the C-reactive protein market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is anticipated to dominate the market in the forecast period due to favorable reimbursement policies.

Asia Pacific is anticipated to be the fastest-growing market region due to increasing government initiative toward R&D projects and improving the healthcare sector. Besides, progression in technology will boost the market growth in the coming years.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

C-Reactive Protein Market Share

The C-reactive protein market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to C-reactive protein market.

C-Reactive Protein Market Leaders Operating in the Market Are:

• Thermo Fisher Scientific, Inc. (U.S)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Danaher (U.S.)
• Quest Diagnostics Incorporated (U.S)
• Siemens Healthcare GmbH (Germany)
• Abbott (U.S)
• Merck KGaA (Germany)
• Zoetis (U.S)
• Ortho Clinical Diagnostics (U.S.)
• Getein Biotech, Inc. (China)
• HORIBA, Ltd (Japan)
• Randox Laboratories Ltd. (U.K)
• Boditech Med, Inc. (South Korea)
• Aidian (Finland)
• SD Biosensor, INC. (South Korea)
• Teco Diagnostics (U.S)
• Arlington Scientific, Inc. (U.S)

Latest Developments in C-Reactive Protein Market

• В октябре 2018 года компания RPS Diagnostics, Inc сообщила, что ее тест FebriDx получил маркировку CE. В течение 10 минут врачи смогут исследовать иммунный ответ организма на острую респираторную инфекцию с помощью образца крови из пальца. Это устройство было создано специально для выявления различных состояний и ОРВИ.

SKU-56077